These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22563186)

  • 21. Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.
    Iwasa M; Sugimoto R; Ishihara T; Sekoguchi-Fujikawa N; Yoshikawa K; Mifuji-Moroka R; Tanaka H; Kobayashi Y; Hasegawa H; Takei Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):433-40. PubMed ID: 26875483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance.
    Yoshiji H; Noguchi R; Namisaki T; Moriya K; Kitade M; Aihara Y; Douhara A; Yamao J; Fujimoto M; Toyohara M; Mitoro A; Sawai M; Yoshida M; Morioka C; Uejima M; Uemura M; Fukui H
    Oncol Rep; 2013 Aug; 30(2):545-52. PubMed ID: 23708326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of molar ratio of branched-chain amino acids to tyrosine (BTR) associated with liver fibrosis in chronic hepatitis C patients treated with interferon-alpha.
    Ninomiya T; Yoon S; Sugano M; Kumon Y; Seo Y; Shimizu K; Nagano H; Kasuga M; Hayashi Y
    Dig Dis Sci; 1999 May; 44(5):1027-33. PubMed ID: 10235614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Molar Ratio of Total Branched-chain Amino Acids to Tyrosine Predicts a Digit Symbol Test Abnormality in Cirrhotic Patients.
    Mizuno Y; Ishikawa T; Ishida J; Kobayashi A; Konakahara Y; Kinoshita A; Hama H; Hokari A; Saruta M
    Intern Med; 2020 Jul; 59(14):1695-1704. PubMed ID: 32296001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.
    Kinny-Köster B; Bartels M; Becker S; Scholz M; Thiery J; Ceglarek U; Kaiser T
    PLoS One; 2016; 11(7):e0159205. PubMed ID: 27410482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xenogeneic, extracorporeal liver perfusion in primates improves the ratio of branched-chain amino acids to aromatic amino acids (Fischer's ratio).
    Schön MR; Heil W; Lemmens HP; Padval D; Matthes M; Puhl G; Neuhaus P; Hammer C
    Eur Surg Res; 1999; 31(3):230-9. PubMed ID: 10352351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and prognostic significance of preoperative serum zinc status in patients with hepatocellular carcinoma after initial hepatectomy.
    Imai K; Beppu T; Yamao T; Okabe H; Hayashi H; Nitta H; Hashimoto D; Mima K; Nakagawa S; Sakamoto K; Chikamoto A; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Nov; 21(12):3817-26. PubMed ID: 24841354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
    Kawaguchi T; Izumi N; Charlton MR; Sata M
    Hepatology; 2011 Sep; 54(3):1063-70. PubMed ID: 21563202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of branched-chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma.
    Okabayashi T; Nishimori I; Sugimoto T; Maeda H; Dabanaka K; Onishi S; Kobayashi M; Hanazaki K
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1869-73. PubMed ID: 18717761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum amino acid levels in patients with hepatocellular carcinoma.
    Watanabe A; Higashi T; Sakata T; Nagashima H
    Cancer; 1984 Nov; 54(9):1875-82. PubMed ID: 6090002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are Supplemental Branched-Chain Amino Acids Beneficial During the Oncological Peri-Operative Period: A Systematic Review and Meta-Analysis.
    Cogo E; Elsayed M; Liang V; Cooley K; Guerin C; Psihogios A; Papadogianis P
    Integr Cancer Ther; 2021; 20():1534735421997551. PubMed ID: 33648360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of the plasma branched-chain amino acid/aromatic amino acid ratio for predicting future cardiac events in patients with heart failure.
    Hiraiwa H; Okumura T; Kondo T; Kato T; Kazama S; Ishihara T; Iwata E; Shimojo M; Kondo S; Aoki S; Kanzaki Y; Tanimura D; Sano H; Awaji Y; Yamada S; Murohara T
    J Cardiol; 2020 Jun; 75(6):689-696. PubMed ID: 32001073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination PEG-IFN a-2b/ribavirin therapy following treatment of hepatitis C virus-associated hepatocellular carcinoma is capable of improving hepatic functional reserve and survival.
    Ishikawa T; Higuchi K; Kubota T; Seki K; Honma T; Yoshida T; Kamimura T
    Hepatogastroenterology; 2012; 59(114):529-32. PubMed ID: 22024226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the molar ratio of branched-chain to aromatic amino acids on growth and albumin mRNA expression of human liver cancer cell lines in a serum-free medium.
    Saito Y; Saito H; Nakamura M; Wakabayashi K; Takagi T; Ebinuma H; Ishii H
    Nutr Cancer; 2001; 39(1):126-31. PubMed ID: 11588894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk stratification using a novel liver functional reserve score of combination prothrombin time-international normalized ratio to albumin ratio and albumin in patients with hepatocellular carcinoma.
    Haruki K; Shiba H; Saito N; Horiuchi T; Shirai Y; Fujiwara Y; Furukawa K; Sakamoto T; Yanaga K
    Surgery; 2018 Sep; 164(3):404-410. PubMed ID: 29754978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. The San-in Group of Liver Surgery.
    Br J Surg; 1997 Nov; 84(11):1525-31. PubMed ID: 9393270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Nishikawa H; Osaki Y; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Henmi S; Sakamoto A; Ishikawa T; Saito S; Kita R; Kimura T
    World J Gastroenterol; 2012 Mar; 18(12):1379-84. PubMed ID: 22493552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma.
    Suzuki H; Mori M; Kawaguchi C; Adachi M; Miura S; Ishii H
    Int J Oncol; 1999 Jun; 14(6):1087-90. PubMed ID: 10339662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.